Lázár Z, Huszár E, Kullmann T, Barta I, Antus B, Bikov A, Kollai M, Horváth I
Department of Pathophysiology, National Korányi Institute for TB and Pulmonology, Budapest, Hungary.
Inflamm Res. 2008 Aug;57(8):367-73. doi: 10.1007/s00011-008-8009-6.
The effect of hypoxic relapse of chronic obstructive pulmonary disease (COPD) on lung adenosine triphosphate (ATP) concentration was studied measuring ATP in exhaled breath condensate (EBC).
Thirty COPD patients with severe exacerbation, thirteen healthy non-smokers and thirteen healthy smokers.
ATP was detected using a luciferin-luciferase assay, dilution of airway droplets in EBC was assessed measuring sample conductivity.
ATP concentrations were similar in COPD patients, non-smoking and smoking healthy individuals (141 +/- 44, 115 +/- 21 and 90 +/- 15 pM; p = 0.66). After treatment oxygenation of COPD patients improved (6.85 +/- 1.29 kPa vs. 8.20 +/- 1.28 kPa, p < 0.001), but EBC ATP concentration was similar to that of admission (p = 0.84). There was no correlation between EBC ATP concentration and airway droplet dilution.
ATP detected in EBC indicates the presence of ATP in airway lining fluid. Lack of difference in ATP concentration between health and COPD suggests that airway ATP level is under complex control of multiple factors.
通过测量呼出气体冷凝液(EBC)中的三磷酸腺苷(ATP),研究慢性阻塞性肺疾病(COPD)缺氧复发对肺ATP浓度的影响。
30例重度加重期COPD患者、13名健康非吸烟者和13名健康吸烟者。
采用荧光素-荧光素酶法检测ATP,通过测量样品电导率评估EBC中气道液滴的稀释情况。
COPD患者、非吸烟和吸烟健康个体的ATP浓度相似(分别为141±44、115±21和90±15 pM;p = 0.66)。COPD患者治疗后氧合改善(6.85±1.29 kPa对8.20±1.28 kPa,p < 0.001),但EBC中ATP浓度与入院时相似(p = 0.84)。EBC中ATP浓度与气道液滴稀释之间无相关性。
EBC中检测到的ATP表明气道衬液中存在ATP。健康者与COPD患者之间ATP浓度缺乏差异,提示气道ATP水平受多种因素的复杂调控。